Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 640

Results For "ED"

7967 News Found

I Peace triples GMP cell manufacturing by expanding CDMO facility
Biotech | March 15, 2022

I Peace triples GMP cell manufacturing by expanding CDMO facility

The facility registration, along with DMF registration and GMP certification provides peace of mind to clients looking to use our iPSCs for clinical and commercial use in the United States, Japan, and other global markets


NuclixBio and PharmAbcine sign collaborative research agreement
Biotech | March 15, 2022

NuclixBio and PharmAbcine sign collaborative research agreement

Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA’ to develop novel mRNA therapeutics that can generate PharmAbcine's antibodies


Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation
Biotech | March 15, 2022

Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation

Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder


UST launches new digital patient engagement solution in partnership with Well-Beat
Digitisation | March 15, 2022

UST launches new digital patient engagement solution in partnership with Well-Beat

The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective


Illumina unveils pathbreaking genomic profiling test for cancer in Europe
Medical Device | March 15, 2022

Illumina unveils pathbreaking genomic profiling test for cancer in Europe

The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey


AbbVie and Scripps Research plan to develop anti-viral for Covid-19
News | March 15, 2022

AbbVie and Scripps Research plan to develop anti-viral for Covid-19

The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation


USFDA grants Orphan Drug Designation for Akantior
Biotech | March 15, 2022

USFDA grants Orphan Drug Designation for Akantior

SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets


Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
News | March 15, 2022

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023


Uniphore and SpinSci join hands to improve patient access and engagement
Digitisation | March 15, 2022

Uniphore and SpinSci join hands to improve patient access and engagement

Deploying solutions like Uniphore’s U-Self Serve and U-Assist with SpinSci’s Patient Engage and Patient Assist is an important step forward in creating frictionless patient experiences


Granules Pharmaceuticals clears USFDA audit
News | March 15, 2022

Granules Pharmaceuticals clears USFDA audit

This is the sixth successful USFDA audit for this facility